Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8601188
Reference Type
Journal Article
Title
MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features
Author(s)
Tonduti, D; Vanderver, A; Berardinelli, A; Schmidt, JL; Collins, CD; Novara, F; Genni, AD; Mita, A; Triulzi, F; Brunstrom-Hernandez, JE; Zuffardi, O; Balottin, U; Orcesi, S
Year
2013
Is Peer Reviewed?
Yes
Journal
Journal of Child Neurology
ISSN:
0883-0738
EISSN:
1708-8283
Volume
28
Issue
6
Page Numbers
795-800
Language
English
PMID
22805248
DOI
10.1177/0883073812450944
Abstract
Monocarboxylate transporter 8 (MCT8) deficiency is an X-linked disorder resulting from an impairment of the transcellular transportation of thyroid hormones. Within the central nervous system thyroid hormone transport is normally mediated by MCT8. Patients are described as affected by a static or slowly progressive clinical picture which consists of variable degrees of mental retardation, hypotonia, spasticity, ataxia and involuntary movements, occasionally paroxysmal. The authors describe the clinical and neuroradiological picture of 3 males patients with marked delayed brain myelination and in which the clinical picture was dominated by early onset nonparoxysmal extrapyramidal symptoms. In one subject a novel mutation is described.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity